The list price of Basaglar will be $316.85 for a pack of five pens ... of Lantus. The companies also hope to steal market share from Novo Nordisk, undercutting the long-acting Levemir (insulin ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning ... Eli Lilly/Boehringer Ingelheim's Basaglar – was approved in the US in 2017, but ...